The invention relates to hepatitis C virus epitopes which are CD4.sup.+ T-lymphocyte specific, and to vaccines containing these epitopes.

 
Web www.patentalert.com

> Targeting of SALL4 for the treatment and diagnosis of proliferative disorders associated with myelodysplastic syndrome (MDS)
~ 00377